ProQR Doses First Patient in Phase 2/3 ILLUMINATE Trial of Sepofarsen for LCA10 Press release LEIDEN, The Netherlands and CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 15, 2019
ProQR Announces Annual Meeting of Shareholders Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 18, 2019
ProQR Announces Annual Meeting of Shareholders Press release Leiden, Netherlands & Cambridge, Mass., May 25, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 25, 2020
ProQR Announces Annual Meeting of Shareholders Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., April 20, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 20, 2021
ProQR to Participate in the Cantor Virtual Rare Orphan Disease Summit Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. March 23, 2022
ProQR Announces Participation in Upcoming Kempen Life Sciences Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 22, 2021
ProQR to Present at Upcoming SVB Leerink Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 07, 2022
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 11, 2021
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. March 02, 2021